Filing Flows

Filing Flows › Companies › Kewaunee Scientific › Cash flow

Kewaunee Scientific cash flow, quarter by quarter

Latest: Q1 FY27 · from the cash-flow statements filed with the SEC

Free cash flow$1.2M in Q1 FY27 · $10.9M over twelve months

Operating cash flow$2.0M
Capital spending−$772K
Free cash flow+$1.2M
Cash / net income1.1×
Cash conversion cycle97 days

Analysis

In Q1 FY27, Kewaunee Scientific generated $2.0M of operating cash flow and spent $772K on capital projects, leaving free cash flow of $1.2M. That is $3.8M less than in Q1 FY26 ($5.0M).

Over the twelve months to Jul 31, 2026, operating cash flow was $14.8M; the largest uses were other financing ($19.8M), capital spending ($3.9M), buybacks ($529K); besides operations, cash came from net borrowing (+) / repaid (−) ($11K); the cash balance fell by $10.2M.

Operating cash flow was $2.0M against net income of $1.8M — 1.1× profit, roughly in line with earnings. The largest differences: payables −$3.0M, stock-based pay +$1.9M, depreciation & amortization +$1.6M.

Its cash conversion cycle was 97 days (receivables 81 + inventory 59 − payables 43).

Free cash flow

Kewaunee Scientific: free cash flow by quarterKewaunee Scientific: free cash flow by quarter$7.8MQ2 FY25−$3.0MQ3 FY25$8.9MQ4 FY25$5.0MQ1 FY26−$5.8MQ2 FY26$11.0MQ3 FY26$4.5MQ4 FY26$1.2MQ1 FY27
Operating cash flow less capital spending.
Kewaunee Scientific: operating cash flow against capital spendingKewaunee Scientific: operating cash flow against capital spendingOperating cash flowCapital spending$8.4M$683KQ2 FY25−$2.3M$689KQ3 FY25$9.4M$516KQ4 FY25$5.8M$771KQ1 FY26−$4.3M$1.6MQ2 FY26$11.6M$668KQ3 FY26$5.5M$928KQ4 FY26$2.0M$772KQ1 FY27
Latest (Q1 FY27): Operating cash flow $2.0M, Capital spending $772K.

Capital allocation, year by year

Kewaunee Scientific: where the cash came from (up) and went (down), by fiscal yearKewaunee Scientific: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingCapital spendingAcquisitionsBuybacksFY22: Operating cash flow −$7.9MFY22: Net borrowing −$4.9MFY22: Capital spending −$1.9MFY22FY23: Operating cash flow −$3.8MFY23: Net borrowing $1.9MFY23: Capital spending −$4.1M$1.9MFY23FY24: Operating cash flow $19.6MFY24: Net borrowing −$462KFY24: Capital spending −$4.4MFY24: Buybacks −$2.0M$19.6MFY24FY25: Operating cash flow $14.8MFY25: Net borrowing $11.5MFY25: Capital spending −$2.2MFY25: Acquisitions −$28.7MFY25: Buybacks −$1.6M$26.3MFY25FY26: Operating cash flow $18.6MFY26: Net borrowing −$1.0MFY26: Capital spending −$3.9M$18.6MFY26
Over these 5 years operating cash flow totalled $41.3M; the largest uses were acquisitions ($28.7M) and capital spending ($16.5M). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$8.2M
Debt$18.9M
Net debt$10.7M
Due within a year$5.1M

Kewaunee Scientific funds itself: free cash flow was $10.9M over the last twelve months, and $8.2M of cash and investments stands against $18.9M of debt ($5.1M due within a year, 1.6× covered by cash).

Where the cash came from and went

Kewaunee Scientific: sources (+) and uses (−) of cash, Q1 FY27Kewaunee Scientific: sources (+) and uses (−) of cash, Q1 FY27Other financing−$2.5MOperating cash flow$2.0MCash drawn (+) / kept (−)$1.4MCapital spending−$772KNet borrowing (+) / repaid (−)$536KBuybacks−$529KExchange rates−$61K
Kewaunee Scientific: sources (+) and uses (−) of cash, TTM to Q1 FY27Kewaunee Scientific: sources (+) and uses (−) of cash, TTM to Q1 FY27Other financing−$19.8MOperating cash flow$14.8MCash drawn (+) / kept (−)$10.2MCapital spending−$3.9MExchange rates−$698KBuybacks−$529KNet borrowing (+) / repaid (−)$11K

From profit to cash

Kewaunee Scientific: net income to operating cash flow, Q1 FY27Kewaunee Scientific: net income to operating cash flow, Q1 FY27Net income$1.8MDepreciation & amortization$1.6MStock-based pay$1.9MReceivables$474KInventory$747KPayables−$3.0MDeferred revenue$1.0MOperating cash flow$2.0M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
QuarterReceivable daysInventory daysPayable daysCash conversion cycle
Q1 FY2781594397
Q4 FY2670564186
Q3 FY2675624295
Q2 FY2676644596
Q1 FY2677624990
Q4 FY2569544380
Q3 FY2568474372
Q2 FY2582525777

Every quarter

QuarterOperating cash flowCapital spendingBuybacksNet borrowing (+) / repaid (−)Cash drawn (+) / kept (−)Free cash flow
Q1 FY27$2.0M−$772K−$529K$536K$1.4M$1.2M
Q4 FY26$5.5M−$928K—−$3.1M−$1.3M$4.5M
Q3 FY26$11.6M−$668K—$407K$3.3M$11.0M
Q2 FY26−$4.3M−$1.6M—−$199K$6.8M−$5.8M
Q1 FY26$5.8M−$771K—−$1.3M−$3.3M$5.0M
Q4 FY25$9.4M−$516K−$1.6M−$2.2M−$4.8M$8.9M
Q3 FY25−$2.3M−$689K—−$187K$17.3M−$3.0M
Q2 FY25$8.4M−$683K—−$3.0M−$4.5M$7.8M

Kewaunee Scientific: income statement and cash flow

Kewaunee Scientific, Q1 FY27: revenue $66.3M (-7% year over year), operating margin 4.8%. The chart follows the revenue to costs, profit and cash.

Kewaunee Scientific: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.